Stunner simultaneously quantifies nanoparticle payloads and measures their size distribution, two critical qualities necessary for an effective nanoparticle vaccine or gene therapy, Unchained said. Moreover, it uses only 2 µL of each sample and performs label-free.

Currently, Stunner provides a method for adeno-associated viruses (AAV) titer and empty/full ratio measurements.

Unchained Labs launches new gene therapy tool
Unchained Labs has launched a new gene therapy quantification application on Stunner, its gene therapy platform.

Bio-Techne opens GMP manufacturing facility
Bio-Techne has opened a 61,000-sq-ft good manufacturing practice (GMP) manufacturing facility in St. Paul, MN. The space will be dedicated to large-scale...

Irvine Scientific to exclusively distribute stem cell tech
Fujifilm Irvine Scientific said it has become the exclusive worldwide distributor of cellnest, a recombinant peptide attachment substrate that's designed...

Amarna Therapeutics, FPS examine gene therapy platform
Amarna Therapeutics will collaborate with scientists from Progreso y Salud Foundation (FPS) of Spain to jointly examine the efficacy of Amarna's Svec...

Bio-Techne, Leica launch RNA probes for COVID-19 research
Bio-Techne and Leica Biosystems have announced the automation of RNAscope COVID-19 probes on Bond Rx, Leica's staining platform, for research use only....